These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8001900)

  • 21. Counterpoint: implantable cardioverter-defibrillator shocks for ventricular tachyarrhythmias do not increase mortality.
    Dorian P
    Heart Rhythm; 2012 Jun; 9(6):988-91. PubMed ID: 22120128
    [No Abstract]   [Full Text] [Related]  

  • 22. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
    Andresen D
    Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sudden cardiac death: who needs an implantable cardioverter-defibrillator and who needs antiarrhythmic drugs?
    Ferrari R; Cinca J; Marber M
    Eur Heart J; 1999 Mar; 20(6):397-8. PubMed ID: 10213339
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH; Yee R; Jung W
    J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
    Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
    Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators.
    Tandri H; Griffith LS; Tang T; Nasir K; Zardkoohi O; Reddy CV; Capps M; Calkins H; Donahue JK
    Heart Rhythm; 2006 Jul; 3(7):762-8. PubMed ID: 16818202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How implantable cardioverter-defibrillators work and simple programming.
    Bryant RM
    Cardiol Young; 2017 Jan; 27(S1):S121-S125. PubMed ID: 28084970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wearable cardioverter defibrillator: a life vest till the life boat (ICD) arrives.
    Francis J; Reek S
    Indian Heart J; 2014; 66(1):68-72. PubMed ID: 24581099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sudden death risk in syncope: the role of the implantable cardioverter defibrillator.
    Olshansky B; Sullivan RM
    Prog Cardiovasc Dis; 2013; 55(4):443-53. PubMed ID: 23472783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent ventricular arrhythmia storms in the age of implantable cardioverter defibrillator therapy: a comprehensive review.
    Huang DT; Traub D
    Prog Cardiovasc Dis; 2008; 51(3):229-36. PubMed ID: 19026857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implantable cardioverter-defibrillator advances.
    Lerman RD; Cannom DS
    Curr Opin Cardiol; 1996 Jan; 11(1):16-22. PubMed ID: 8664527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The subcutaneous implantable cardioverter-defibrillator: Current trends in clinical practice between guidelines and technology progress.
    Adduci C; Ali H; Francia P; Mantovani R; Palano F; Lupo P; Foresti S; De Ambroggi G; Cappato R
    Eur J Intern Med; 2019 Jul; 65():6-11. PubMed ID: 31005441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions between antiarrhythmic drugs and implantable cardioverter-defibrillators.
    Dougherty AH
    Curr Opin Cardiol; 1996 Jan; 11(1):2-8. PubMed ID: 8664528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
    JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.